Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics Profiling

Journal of Proteome Research

Volumn 10, Issue 5, 2011, Pages 2359-2376

  Pan, Sheng ^a   Chen, Ru ^a   Crispin, David A ^a   May, Damon ^b   Stevens, Tyler ^c   McIntosh, Martin W ^b   Bronner, Mary P ^c   Ziogas, Argyrios ^d   Anton Culver, Hoda ^d   Brentnall, Teresa A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomarker; chronic pancreatitis; ELISA; mass spectrometry; pancreatic cancer; plasma; proteomics; serum

Indexed keywords

APOLIPOPROTEIN A2; BIOLOGICAL MARKER; CA 19-9 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LACTOFERRIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; PLASMA PROTEIN; PROTEIN AZGP1; PROTEOME; RANTES; THROMBOCYTE BASIC PROTEIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CHRONIC PANCREATITIS; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GOLD STANDARD; HUMAN; LETHALITY; PANCREAS CANCER; PANCREAS JUICE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; SURVIVAL RATE; TECHNOLOGY;

BLOOD PROTEINS; CARRIER PROTEINS; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PROTEOMICS; TANDEM MASS SPECTROMETRY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MARKERS, BIOLOGICAL;

EID: 79955876081     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr101148r     Document Type: Article

References (77)

1. Brand, R. The diagnosis of pancreatic cancer Cancer J. 2001, 7, 287-97
2. Jemal, A.; Thomas, A.; Murray, T.; Thun, M. Cancer statistics, 2002 CA Cancer J. Clin. 2002, 52, 23-47 (Pubitemid 34110469)
3. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Smigal, C.; Thun, M. J. Cancer statistics, 2006 CA Cancer J. Clin. 2006, 56, 106-30
4. Pleskow, D. K.; Berger, H. J.; Gyves, J.; Allen, E.; McLean, A.; Podolsky, D. K. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer Ann. Intern. Med. 1989, 110, 704-09 (Pubitemid 19121224)
5. Rosty, C.; Goggins, M. Early detection of pancreatic carcinoma Hematol. Oncol. Clin. North Am. 2002, 16, 37-52 (Pubitemid 34578625)
6. Ludwig, J. A.; Weinstein, J. N. Biomarkers in cancer staging, prognosis and treatment selection Nat. Rev. Cancer 2005, 5, 845-56 (Pubitemid 41746029)
7. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics Nature 2003, 422, 198-207 (Pubitemid 36362757)
8. Chen, R; Pan, S; Aebersold, R; Brentnall, T. A. Proteomics studies of pancreatic cancer Proteomics Clin. Appl. 2007, 1, 1582-91
9. Chen, R.; Pan, S.; Brentnall, T. A.; Aebersold, R. Proteomic profiling of pancreatic cancer for biomarker discovery Mol. Cell. Proteomics 2005, 4, 523-33 (Pubitemid 40590569)
10. Goggins, M. Molecular markers of early pancreatic cancer J. Clin. Oncol. 2005, 23, 4524-31 (Pubitemid 46196582)
11. Grantzdorffer, I.; Carl-McGrath, S.; Ebert, M. P.; Rocken, C. Proteomics of pancreatic cancer Pancreas 2008, 36, 329-36 (Pubitemid 351591573)
12. Tonack, S.; Aspinall-O'Dea, M.; Neoptolemos, J. P.; Costello, E. Pancreatic cancer: proteomic approaches to a challenging disease Pancreatology 2009, 9, 567-76
13. Vimalachandran, D.; Costello, E. Proteomic technologies and their application to pancreatic cancer Expert Rev. Proteomics 2004, 1, 493-501 (Pubitemid 43826414)
14. Yu, K. H.; Barry, C. G.; Austin, D.; Busch, C. M.; Sangar, V.; Rustgi, A. K.; Blair, I. A. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery J. Proteome Res. 2009, 8, 1565-76
15. Faca, V. M.; Song, K. S.; Wang, H.; Zhang, Q.; Krasnoselsky, A. L.; Newcomb, L. F.; Plentz, R. R.; Gurumurthy, S.; Redston, M. S.; Pitteri, S. J.; Pereira-Faca, S. R.; Ireton, R. C.; Katayama, H.; Glukhova, V.; Phanstiel, D.; Brenner, D. E.; Anderson, M. A.; Misek, D.; Scholler, N.; Urban, N. D.; Barnett, M. J.; Edelstein, C.; Goodman, G. E.; Thornquist, M. D.; McIntosh, M. W.; DePinho, R. A.; Bardeesy, N.; Hanash, S. M. A mouse to human search for plasma proteome changes associated with pancreatic tumor development PLoS Med. 2008, 5, e123
16. Omenn, G. S. Advancement of biomarker discovery and validation through the HUPO plasma proteome project Dis. Markers 2004, 20, 131-34 (Pubitemid 39314342)
17. Omenn, G. S. The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses Proteomics 2004, 4, 1235-40 (Pubitemid 38648012)
18. States, D. J.; Omenn, G. S.; Blackwell, T. W.; Fermin, D.; Eng, J.; Speicher, D. W.; Hanash, S. M. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study Nat. Biotechnol. 2006, 24, 333-38 (Pubitemid 43372157)
19. Surinova, S.; Schiess, R.; Huttenhain, R.; Cerciello, F.; Wollscheid, B.; Aebersold, R. On the Development of Plasma Protein Biomarkers J. Proteome Res. 2011, 10, 5-16
20. Stevens, T.; Dumot, J. A.; Parsi, M. A.; Zuccaro, G.; Vargo, J. J. Combined endoscopic ultrasound and secretin endoscopic pancreatic function test in patients evaluated for chronic pancreatitis Dig. Dis. Sci. 2010, 55, 2681-87
21. Faca, V.; Coram, M.; Phanstiel, D.; Glukhova, V.; Zhang, Q.; Fitzgibbon, M.; McIntosh, M.; Hanash, S. Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS J. Proteome Res. 2006, 5, 2009-18 (Pubitemid 44232714)
22. Craig, R.; Beavis, R. C. TANDEM: matching proteins with tandem mass spectra Bioinformatics 2004, 20, 1466-67 (Pubitemid 38931421)
23. Keller, A.; Eng, J.; Zhang, N.; Li, X. J.; Aebersold, R. A uniform proteomics MS/MS analysis platform utilizing open XML file formats Mol. Syst. Biol. 2005, 1, 2005
24. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74, 5383-92 (Pubitemid 35215372)
25. May, D.; Law, W.; Fitzgibbon, M.; Fang, Q.; McIntosh, M. Software platform for rapidly creating computational tools for mass spectrometry-based proteomics J. Proteome Res. 2009, 8, 3212-17
26. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75, 4646-58 (Pubitemid 37082259)
27. Palmer, C.; Duan, X.; Hawley, S.; Scholler, N.; Thorpe, J. D.; Sahota, R. A.; Wong, M. Q.; Wray, A.; Bergan, L. A.; Drescher, C. W.; McIntosh, M. W.; Brown, P. O.; Nelson, B. H.; Urban, N. Systematic evaluation of candidate blood markers for detecting ovarian cancer PLoS One 2008, 3, e2633
28. Omenn, G. S.; States, D. J.; Adamski, M.; Blackwell, T. W.; Menon, R.; Hermjakob, H.; Apweiler, R.; Haab, B. B.; Simpson, R. J.; Eddes, J. S.; Kapp, E. A.; Moritz, R. L.; Chan, D. W.; Rai, A. J.; Admon, A.; Aebersold, R.; Eng, J.; Hancock, W. S.; Hefta, S. A.; Meyer, H.; Paik, Y. K.; Yoo, J. S.; Ping, P.; Pounds, J.; Adkins, J.; Qian, X.; Wang, R.; Wasinger, V.; Wu, C. Y.; Zhao, X.; Zeng, R.; Archakov, A.; Tsugita, A.; Beer, I.; Pandey, A.; Pisano, M.; Andrews, P.; Tammen, H.; Speicher, D. W.; Hanash, S. M. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database Proteomics 2005, 5, 3226-45 (Pubitemid 41192032)
29. Chen, R.; Pan, S.; Yi, E. C.; Donohoe, S.; Bronner, M. P.; Potter, J. D.; Goodlett, D. R.; Aebersold, R.; Brentnall, T. A. Quantitative proteomic profiling of pancreatic cancer juice Proteomics 2006, 6, 3871-79 (Pubitemid 44065164)
30. Chen, R.; Pan, S.; Cooke, K.; Moyes, K. W.; Bronner, M. P.; Goodlett, D. R.; Aebersold, R.; Brentnall, T. A. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis Pancreas 2007, 34, 70-79 (Pubitemid 46045723)
31. Chen, R.; Brentnall, T. A.; Pan, S.; Cooke, K.; Moyes, K. W.; Lane, Z.; Crispin, D. A.; Goodlett, D. R.; Aebersold, R.; Bronner, M. P. Quantitative Proteomics Analysis Reveals That Proteins Differentially Expressed in Chronic Pancreatitis Are Also Frequently Involved in Pancreatic Cancer Mol. Cell. Proteomics 2007, 6, 1331-42 (Pubitemid 47365432)
32. Chen, R.; Yi, E. C.; Donohoe, D.; Pan, S.; Eng, J.; Crispin, D. A.; Lane, Z.; Goodlett, D. A.; Bronner, M. P.; Aebersold, R.; Brentnall, T. A. Pancreatic Cancer Proteome: the Proteins that Underlie Invasion, Metastasis, and Immunologic Escape Gastroenterology 2005, 129, 1187-97 (Pubitemid 41446859)
33. Pan, S.; Chen, R.; Reimel, B. A.; Crispin, D. A.; Mirzaei, H.; Cooke, K.; Coleman, J. F.; Lane, Z.; Bronner, M. P.; Goodlett, D. R.; McIntosh, M. W.; Traverso, W.; Aebersold, R.; Brentnall, T. A. Quantitative proteomics investigation of pancreatic intraepithelial neoplasia Electrophoresis 2009, 30, 1132-44
34. Polanski, M.; Anderson, N. L. A list of candidate cancer biomarkers for targeted proteomics Biomarker Insights 2007, 1, 1-48
35. Qian, W. J.; Kaleta, D. T.; Petritis, B. O.; Jiang, H.; Liu, T.; Zhang, X.; Mottaz, H. M.; Varnum, S. M.; Camp, D. G.; Huang, L.; Fang, X.; Zhang, W. W.; Smith, R. D. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy Mol. Cell. Proteomics 2008, 7, 1963-73
36. Deng, R.; Lu, Z.; Chen, Y.; Zhou, L.; Lu, X. Plasma proteomic analysis of pancreatic cancer by 2-dimensional gel electrophoresis Pancreas 2007, 34, 310-17 (Pubitemid 46588256)
37. Sun, Z. L.; Zhu, Y.; Wang, F. Q.; Chen, R.; Peng, T.; Fan, Z. N.; Xu, Z. K.; Miao, Y. Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers Biochim. Biophys. Acta 2007, 1774, 764-71 (Pubitemid 46856286)
38. Bloomston, M.; Zhou, J. X.; Rosemurgy, A. S.; Frankel, W.; Muro-Cacho, C. A.; Yeatman, T. J. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples Cancer Res. 2006, 66, 2592-99
39. Bjorhall, K.; Miliotis, T.; Davidsson, P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples Proteomics 2005, 5, 307-17 (Pubitemid 40189661)
40. Roche, S.; Tiers, L.; Provansal, M.; Seveno, M.; Piva, M. T.; Jouin, P.; Lehmann, S. Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better? J. Proteomics 2009, 72, 945-51
41. Zolotarjova, N.; Martosella, J.; Nicol, G.; Bailey, J.; Boyes, B. E.; Barrett, W. C. Differences among techniques for high-abundant protein depletion Proteomics 2005, 5, 3304-13 (Pubitemid 41192037)
42. Tu, C.; Rudnick, P. A.; Martinez, M. A.; Cheek, K. L.; Stein, S. E.; Slebos, R. J.; Liebler, D. C. Depletion of abundant plasma proteins and limitations of plasma proteomics J. Proteome Res. 2010, 9 (10) 4892-91
43. Ozaki, N.; Ohmuraya, M.; Hirota, M.; Ida, S.; Wang, J.; Takamori, H.; Higashiyama, S.; Baba, H.; Yamamura, K. Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor Mol. Cancer Res. 2009, 7, 1572-81
44. Whitcomb, D. C. Genetic aspects of pancreatitis Annu. Rev. Med. 2010, 61, 413-24
45. McElroy, M. K.; Kaushal, S.; Tran Cao, H. S.; Moossa, A. R.; Talamini, M. A.; Hoffman, R. M.; Bouvet, M. Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis Mol. Cancer Ther. 2009, 8, 1779-86
46. Tobita, K.; Kijima, H.; Dowaki, S.; Oida, Y.; Kashiwagi, H.; Ishii, M.; Sugio, Y.; Sekka, T.; Ohtani, Y.; Tanaka, M.; Inokuchi, S.; Makuuchi, H. Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma Int. J. Oncol. 2002, 21, 1189-95
47. Neuschwander-Tetri, B. A.; Talkad, V. Otis, Stephen F. Induced thrombospondin expression in the mouse pancreas during pancreatic injury Int. J. Biochem. Cell Biol. 2006, 38, 102-09 (Pubitemid 41540721)
48. Charrier, A. L.; Brigstock, D. R. Connective tissue growth factor production by activated pancreatic stellate cells in mouse alcoholic chronic pancreatitis Lab. Invest. 2010, 90, 1179-88
49. Seeliger, H.; Camaj, P.; Ischenko, I.; Kleespies, A.; De Toni, E. N.; Thieme, S. E.; Blum, H.; Assmann, G.; Jauch, K. W.; Bruns, C. J. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma Mol. Cancer Res. 2009, 7, 189-98
50. Chen, Y.; Yu, G.; Yu, D.; Zhu, M. PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1 J. Exp. Clin. Cancer Res. 2010, 29, 104
51. Lewis, A.; Du, J.; Liu, J.; Ritchie, J. M.; Oberley, L. W.; Cullen, J. J. Metastatic progression of pancreatic cancer: changes in antioxidant enzymes and cell growth Clin. Exp. Metastasis 2005, 22, 523-32 (Pubitemid 43234636)
52. Liu, J.; Hinkhouse, M. M.; Sun, W.; Weydert, C. J.; Ritchie, J. M.; Oberley, L. W.; Cullen, J. J. Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype Hum. Gene Ther. 2004, 15, 239-50 (Pubitemid 38365913)
53. Wereszczynska-Siemiatkowska, U.; Mroczko, B.; Siemiatkowski, A.; Szmitkowski, M.; Borawska, M.; Kosel, J. The importance of interleukin 18, glutathione peroxidase, and selenium concentration changes in acute pancreatitis Dig. Dis. Sci. 2004, 49, 642-50 (Pubitemid 38992556)
54. Albrethsen, J.; Moller, C. H.; Olsen, J.; Raskov, H.; Gammeltoft, S. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer Eur. J. Cancer 2006, 42, 3057-64 (Pubitemid 44679822)
55. Melle, C.; Osterloh, D.; Ernst, G.; Schimmel, B.; Bleul, A.; von Eggeling, F. Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry Int. J. Mol. Med. 2005, 16, 11-17
56. Correa, C. R.; Bertollo, C. M.; Zouain, C. S.; Goes, A. M. Glyceraldehyde-3-phosphate dehydrogenase as a surface associated antigen on human breast cancer cell lines MACL-1 and MGSO-3 Oncol. Rep. 2010, 24, 677-85
57. Chen, Y.; Zhang, H.; Xu, A.; Li, N.; Liu, J.; Liu, C.; Lv, D.; Wu, S.; Huang, L.; Yang, S.; He, D.; Xiao, X. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer Lung Cancer 2006, 54, 95-102
58. Leiblich, A.; Cross, S. S.; Catto, J. W.; Phillips, J. T.; Leung, H. Y.; Hamdy, F. C.; Rehman, I. Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer Oncogene 2006, 25, 2953-60 (Pubitemid 43739247)
59. Liou, J. M.; Shun, C. T.; Liang, J. T.; Chiu, H. M.; Chen, M. J.; Chen, C. C.; Wang, H. P.; Wu, M. S.; Lin, J. T. Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer J. Clin. Endocrinol. Metab 2010, 95, 1717-25
60. So, A. I.; Levitt, R. J.; Eigl, B.; Fazli, L.; Muramaki, M.; Leung, S.; Cheang, M. C.; Nielsen, T. O.; Gleave, M.; Pollak, M. Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer Clin. Cancer Res. 2008, 14, 6944-54
61. Kawashima, Y.; Fukutomi, T.; Tomonaga, T.; Takahashi, H.; Nomura, F.; Maeda, T.; Kodera, Y. High-yield peptide-extraction method for the discovery of subnanomolar biomarkers from small serum samples J. Proteome Res. 2010, 9, 1694-705
62. Yu, Y. P.; Luo, J. H. Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin Cancer Res. 2006, 66, 7414-19 (Pubitemid 44289193)
63. Chen, R.; Pan, S.; Duan, X.; Nelson, B. H.; Sahota, R. A.; de Rham, S.; Kozarek, R. A.; McIntosh, M.; Brentnall, T. A. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia Mol. Cancer 2010, 9, 149
64. Ramachandran, V.; Arumugam, T.; Wang, H.; Logsdon, C. D. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival Cancer Res. 2008, 68, 7811-18
65. Duncan, M. W.; Aebersold, R.; Caprioli, R. M. The pros and cons of peptide-centric proteomics Nat. Biotechnol. 2010, 28, 659-64
66. Sandblom, G.; Granroth, S.; Rasmussen, I. C. TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head Ups. J. Med. Sci. 2008, 113, 57-64
67. Chen, R.; Crispin, D. A.; Pan, S.; Hawley, S.; McIntosh, M. W.; May, D.; Anton-Culver, H.; Ziogas, A.; Bronner, M. P.; Brentnall, T. A. Pilot Study of Blood Biomarker Candidates for Detection of Pancreatic Cancer. Pancreas 2010, not supplied.
68. Markocka-Maczka, K. [Concentration of serum soluble forms of ICAM-1 (sVCAM-1) and VCAM-1 (sVCAM-1) in patients with chronic pancreatitis and in patients with pancreatic carcinoma] Wiad. Lek. 2003, 56, 147-51
69. Zhou, W.; Sokoll, L. J.; Bruzek, D. J.; Zhang, L.; Velculescu, V. E.; Goldin, S. B.; Hruban, R. H.; Kern, S. E.; Hamilton, S. R.; Chan, D. W.; Vogelstein, B.; Kinzler, K. W. Identifying markers for pancreatic cancer by gene expression analysis Cancer Epidemiol. Biomarkers Prev. 1998, 7, 109-12 (Pubitemid 28109841)
70. Gogali, A.; Charalabopoulos, K.; Zampira, I.; Konstantinidis, A. K.; Tachmazoglou, F.; Daskalopoulos, G.; Constantopoulos, S. H.; Dalavanga, Y. Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers Chest 2010, 138, 1173-79
71. Mantur, M.; Snarska, J.; Koper, O.; Dzieciol, J.; Plonski, A.; Lemancewicz, D. Serum sICAM, sVCAM and sE-selectin levels in colorectal cancer patients Folia Histochem. Cytobiol. 2009, 47, 621-25
72. Offenberg, H.; Brunner, N.; Mansilla, F.; Orntoft, T. F.; Birkenkamp-Demtroder, K. TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles Mol. Oncol. 2008, 2, 233-40
73. Pasieka, Z.; Kuzdak, K.; Czyz, W.; Stepien, H.; Komorowski, J. Soluble intracellular adhesion molecules (sICAM-1, sVCAM-1) in peripheral blood of patients with thyroid cancer Neoplasma 2004, 51, 34-37 (Pubitemid 38250154)
74. Wang, C. S.; Wu, T. L.; Tsao, K. C.; Sun, C. F. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker Ann. Clin. Lab. Sci. 2006, 36, 23-30
75. Yamada, M.; Yanaba, K.; Takehara, K.; Sato, S. Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma Arch. Dermatol. Res. 2005, 297, 256-60 (Pubitemid 41712812)
76. Hayakawa, T.; Harada, H.; Noda, A.; Kondo, T. Lactoferrin in pure pancreatic juice in chronic pancreatitis Am. J. Gastroenterol. 1983, 78, 222-24 (Pubitemid 13122729)
77. Jin, C. X.; Hayakawa, T.; Kitagawa, M.; Ishiguro, H. Lactoferrin in chronic pancreatitis J. Pancreas 2009, 10, 237-41